Factors Affecting Drug Dialyzability | Pharmacokinetics in Dialysis

💊 Factors Affecting Drug Dialyzability Pharmacokinetics in Dialysis

The extent to which a drug is removed by dialysis is determined by physicochemical characteristics and technical aspects of the dialysis procedure

Drug dialyzability is influenced by several interrelated factors. The primary determinants include molecular size, protein binding, volume of distribution, water solubility, and plasma clearance. In addition to drug properties, technical aspects of the dialysis procedure — membrane characteristics, blood flow rates, and dialysate flow rates — significantly affect the extent of drug removal. Understanding these factors is essential for appropriate post-dialysis dosing.

⚖️ Molecular Weight

Pore size dependency

Dialysis depends on movement of solutes across a membrane (synthetic or peritoneal). Smaller molecular weight substances pass through more easily than larger molecules.

Low molecular weight (<500 Da): Easily dialyzed
Middle molecular weight (500–15,000 Da): Variable removal, depends on membrane
Large molecular weight (>15,000 Da): Poor dialyzability

                    💡 Peritoneal membrane pore size is generally larger than hemodialysis membranes → larger molecules are removed to a greater extent during PD.
                

🔗 Protein Binding

Free drug concentration gradient

Only unbound (free) drug crosses the dialysis membrane. High protein binding → low free fraction → poor dialyzability.

Low binding (<30%): High dialyzability
Moderate binding (30–80%): Variable dialyzability
High binding (>80%): Poor dialyzability

                    ⚕️ Uremia effect: Protein binding may decrease in uremic serum, potentially increasing dialyzability of free drug. Albumin and α1-acid glycoprotein are too large to cross HD membranes.
                

📊 Volume of Distribution (Vd)

Tissue distribution

Drugs with large Vd are widely distributed in tissues, with small amounts present in blood → minimally dialyzed.

Small Vd (<0.6 L/kg): Likely significant dialyzability
Large Vd (>1 L/kg): Minimal dialyzability

                    🔬 Factors increasing Vd: high lipid solubility, low protein binding. Highly lipophilic drugs are sequestered in tissues → limited removal by dialysis.
                

💧 Water Solubility

Dialysate is aqueous

Drugs with high water solubility are dialyzed more readily than highly lipid-soluble compounds.

Hydrophilic drugs: Higher dialyzability, remain in plasma water
Lipophilic drugs: Lower dialyzability, distribute into tissues

                    📌 Highly lipid-soluble drugs are present in plasma in small fraction → only minimal amount available for dialysis.
                

🧪 Plasma Clearance

Non-renal vs. dialysate clearance

In dialysis patients, renal clearance is largely replaced by dialysate clearance. If non-renal clearance is large compared to dialysate clearance, the contribution of dialysis to total drug removal is low.

                    Clinical threshold: If dialysis increases plasma clearance by ≥30%, it is considered clinically important and may require post-dose supplementation.
                

🧬 Dialysis Membrane

Pore size · Surface area · Geometry

Membrane characteristics are primary determinants of drug dialyzability. Newer membranes may have different drug dialysis properties.

Low-flux membranes: Smaller pore size, limited middle molecule removal
High-flux membranes: Larger pore size, enhanced removal of larger molecules
Peritoneal membrane: Natural, cannot be altered; permits passage of some proteins

                    🔄 Technology evolves — published literature should be interpreted with understanding that newer membranes may differ in drug removal characteristics.
                

🔄 Blood & Dialysate Flow Rates

Flow rates significantly affect drug dialyzability by influencing concentration gradients and mass transfer.

🩸 Hemodialysis:

Increased blood flow → greater drug delivery to membrane → higher removal
Increased dialysate flow → maintains low dialysate drug concentration → enhances gradient

💧 Peritoneal Dialysis:

Blood flow to peritoneum cannot be easily altered
Dialysate flow determined by exchange volume and frequency
More frequent exchanges → increased drug dialyzability (provided drug crosses membrane)
Low exchange rates → dialysate drug concentration rises → slows further movement

                💡 Clinical pearl: During peritonitis, increased protein concentrations in peritoneal effluent may enhance removal of protein-bound drugs.
            

📊 Summary: Factors & Impact on Dialyzability

Factor	Low Dialyzability	High Dialyzability	Clinical Implication
Molecular Weight	>1000 Da	<500 Da	Large molecules poorly removed by HD
Protein Binding	>80% bound	<30% bound	Highly bound drugs require post-dialysis supplementation
Volume of Distribution	>1 L/kg	<0.6 L/kg	Large Vd → minimal dialytic removal
Water Solubility	Lipophilic	Hydrophilic	Hydrophilic drugs more accessible in plasma
Plasma Clearance	High non-renal clearance	Low non-renal clearance	Dialysis contribution significant if ≥30% increase
Membrane Type	Low-flux	High-flux / PD	High-flux removes larger molecules
Blood/Dialysate Flow	Low flow rates	High flow rates	Higher flows enhance removal

HD = Hemodialysis; PD = Peritoneal Dialysis; Vd = Volume of distribution

🧠 Clinical Takeaway: Drug dialyzability is multifactorial. For medications with:

Low molecular weight (<500 Da), low protein binding (<30%), small Vd (<0.6 L/kg), high water solubility → significant dialytic removal → post-dialysis supplementation often required
High molecular weight, high protein binding (>80%), large Vd (>1 L/kg), lipophilic → minimal dialytic removal → standard dosing may suffice

Always consult drug-specific dialyzability data and adjust doses based on dialysis modality, membrane type, and patient-specific factors.